VEGFC and neoplasm: miR-101, miR-128, miR-206 and miR-1826 have been documented to reduce tumor growth, lymphangiogenesis and metastasis by targeting VEGF-C in a variety of human cancer cells24, 25, 26, 40, 41, 42.